4.29
price down icon0.69%   -0.03
after-market Dopo l'orario di chiusura: 4.23 -0.06 -1.40%
loading
Precedente Chiudi:
$4.32
Aprire:
$4.29
Volume 24 ore:
221.34K
Relative Volume:
0.08
Capitalizzazione di mercato:
$75.77M
Reddito:
-
Utile/perdita netta:
$-30.54M
Rapporto P/E:
-2.7677
EPS:
-1.55
Flusso di cassa netto:
$-18.30M
1 W Prestazione:
+0.47%
1M Prestazione:
+2.14%
6M Prestazione:
+724.37%
1 anno Prestazione:
+1,249%
Intervallo 1D:
Value
$4.235
$4.35
Intervallo di 1 settimana:
Value
$4.07
$4.35
Portata 52W:
Value
$0.2833
$8.2457

Unicycive Therapeutics Inc Stock (UNCY) Company Profile

Name
Nome
Unicycive Therapeutics Inc
Name
Telefono
650-384-0642
Name
Indirizzo
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Name
Dipendente
22
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
UNCY's Discussions on Twitter

Confronta UNCY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
UNCY
Unicycive Therapeutics Inc
4.29 74.00M 0 -30.54M -18.30M -1.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.62 100.25B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.80 61.55B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.23 58.53B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
722.01 43.59B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
336.26 33.67B 3.81B -644.79M -669.77M -6.24

Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-21 Iniziato Guggenheim Buy
2024-04-04 Iniziato Piper Sandler Overweight

Unicycive Therapeutics Inc Borsa (UNCY) Ultime notizie

pulisher
12:46 PM

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - FinancialContent

12:46 PM
pulisher
10:23 AM

What MACD and RSI say about Unicycive Therapeutics Inc.2025 Price Targets & Verified Chart Pattern Signals - Newser

10:23 AM
pulisher
10:01 AM

Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain OfficersUNCY - MarketScreener

10:01 AM
pulisher
09:21 AM

Investor Alert: Deadline Approaching to Join Unicycive Therapeutics, Inc. (UNCY) Class ActionContact Levi & Korsinsky - Newsfile

09:21 AM
pulisher
08:01 AM

Risk adjusted return profile for Unicycive Therapeutics Inc. analyzed2025 Winners & Losers & Weekly Setup with High ROI Potential - Newser

08:01 AM
pulisher
07:55 AM

Is Unicycive Therapeutics Inc. stock entering bullish territoryWeekly Gains Report & Daily Profit Focused Screening - Newser

07:55 AM
pulisher
07:46 AM

Shareholders of Unicycive Therapeutics, Inc. (UNCY): Protect Your Rights Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire

07:46 AM
pulisher
06:39 AM

What candlestick patterns are forming on Unicycive Therapeutics Inc.Trade Entry Report & Expert Curated Trade Setup Alerts - Newser

06:39 AM
pulisher
05:46 AM

Risk vs reward if holding onto Unicycive Therapeutics Inc.Weekly Market Outlook & Target Return Focused Stock Picks - Newser

05:46 AM
pulisher
Sep 02, 2025

Custom watchlist performance reports with Unicycive Therapeutics Inc.Short Setup & Capital Efficiency Focused Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Unicycive Therapeutics, Inc. Sued for Securities Law - GlobeNewswire

Sep 02, 2025
pulisher
Sep 02, 2025

Tools to monitor Unicycive Therapeutics Inc. recovery probability2025 Price Action Summary & Long-Term Growth Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is this a good reentry point in Unicycive Therapeutics Inc.July 2025 Market Mood & AI Powered Market Entry Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How to monitor Unicycive Therapeutics Inc. with trend dashboardsPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky to Join Class Action Before October 14, 2025 - ACCESS Newswire

Sep 02, 2025
pulisher
Sep 02, 2025

Earnings visualization tools for Unicycive Therapeutics Inc.2025 Top Gainers & Scalable Portfolio Growth Methods - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can Unicycive Therapeutics Inc. weather a recessionJuly 2025 Action & Accurate Buy Signal Alerts - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

UNCY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 02, 2025
pulisher
Sep 02, 2025

Does Unicycive Therapeutics Inc. have declining or rising EPSJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - خودرو بانک

Sep 02, 2025
pulisher
Sep 01, 2025

Will Unicycive Therapeutics Inc. stock go up in YEARTrade Risk Assessment & AI Forecasted Stock Moves - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Is Unicycive Therapeutics Inc. impacted by rising ratesWeekly Trend Recap & Risk Controlled Daily Plans - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire

Sep 01, 2025
pulisher
Sep 01, 2025

How hedge fund analytics apply to Unicycive Therapeutics Inc. stockWeekly Market Report & Community Consensus Picks - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Aug 31, 2025
pulisher
Aug 31, 2025

Will Unicycive Therapeutics Inc. stock recover after recent dropGold Moves & Long-Term Growth Portfolio Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. (UNCY) Shareholders of Class Action Lawsuit and October 14, 2025 Deadline - ACCESS Newswire

Aug 31, 2025
pulisher
Aug 31, 2025

Is Unicycive Therapeutics Inc. stock reversal real or fakeQuarterly Performance Summary & Community Verified Watchlist Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Levi & Korsinsky Urges Unicycive Therapeutics, Inc. (UNCY) Shareholders to Act Before Lead Plaintiff Deadline October 14, 2025 - ACCESS Newswire

Aug 31, 2025
pulisher
Aug 31, 2025

Candlestick signals on Unicycive Therapeutics Inc. stock today2025 Trading Recap & Daily Stock Trend Reports - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Can machine learning forecast Unicycive Therapeutics Inc. recoveryPortfolio Risk Summary & Stock Market Timing Techniques - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Can momentum traders help lift Unicycive Therapeutics Inc.Weekly Profit Recap & Weekly Watchlist of Top Performers - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Will Unicycive Therapeutics Inc. face regulatory challengesQuarterly Market Review & AI Powered Buy and Sell Recommendations - sundaytimes.kr

Aug 30, 2025
pulisher
Aug 30, 2025

Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Aug 30, 2025
pulisher
Aug 30, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Upgraded by Wall Street Zen to Hold Rating - Defense World

Aug 30, 2025
pulisher
Aug 30, 2025

Is Unicycive Therapeutics Inc. in Accumulation Phase Now getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 30, 2025
pulisher
Aug 30, 2025

How to track smart money flows in Unicycive Therapeutics Inc.Jobs Report & Free Community Consensus Stock Picks - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Combining machine learning predictions for Unicycive Therapeutics Inc.2025 Top Gainers & Daily Price Action Insights - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Faruqi & Faruqi investigates Unicycive Therapeutics securities class action. - AInvest

Aug 29, 2025
pulisher
Aug 29, 2025

Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCY - FinancialContent

Aug 29, 2025
pulisher
Aug 29, 2025

Published on: 2025-08-29 05:29:20 - Newser

Aug 29, 2025

Unicycive Therapeutics Inc Azioni (UNCY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$86.96
price up icon 1.14%
$27.08
price up icon 4.60%
$23.52
price down icon 1.34%
$100.42
price down icon 0.20%
$143.50
price down icon 1.24%
biotechnology ONC
$336.26
price up icon 1.27%
Capitalizzazione:     |  Volume (24 ore):